{
  "paper_metadata": {
    "pmid": "35414855",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Individuals from endemic areas in Portugal, Brazil, and Japan",
        "phenotype": "Familial amyloid polyneuropathy (FAP) with high penetrance"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": [
          {
            "age_range": "50 years",
            "penetrance_percentage": 80.0,
            "carriers_in_range": 1,
            "affected_in_range": 1
          },
          {
            "age_range": "50 years (Sweden)",
            "penetrance_percentage": 11.0,
            "carriers_in_range": 1,
            "affected_in_range": 0
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": 30,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "Symptoms of familial amyloid polyneuropathy",
          "evidence_sentence": "In endemic areas of Portugal, the penetrance is high, with approximately 80% developing disease by age 50 years."
        }
      ],
      "functional_data": {
        "summary": "The Val30Met variant is known to cause FAP and has high penetrance in endemic regions.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families in endemic areas.",
      "population_frequency": "Prevalence of 4% in northern Sweden, 1:538 in northern Portugal.",
      "evidence_level": "Strong evidence based on population studies.",
      "source_location": "Specific section on Val30Met in the Genetics section.",
      "additional_notes": "High penetrance in endemic areas, variable penetrance in non-endemic areas.",
      "key_quotes": [
        "In endemic areas of Portugal, the penetrance is high, with approximately 80% developing disease by age 50 years.",
        "Despite the high frequency of the Val30Met mutation in the endemic areas of Sweden (4%), there is relatively low penetrance: 11% by age 50."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Val122Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Approximately 3.4% among African Americans",
        "phenotype": "Cardiac amyloidosis, typically presenting after age 60"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P2",
          "age_at_evaluation": 65,
          "age_at_onset": 60,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "Cardiac phenotype with neurologic symptoms",
          "evidence_sentence": "The Val122Ile mutation has been found in 10% of African Americans over the age of 65 years who have severe HF."
        }
      ],
      "functional_data": {
        "summary": "The Val122Ile variant leads to misfolding of TTR monomers and is associated with a cardiac phenotype.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Prevalence of approximately 3.4% among African Americans.",
      "evidence_level": "Moderate evidence based on population studies.",
      "source_location": "Specific section on Val122Ile in the Genetics section.",
      "additional_notes": "Age-dependent penetrance is not well defined.",
      "key_quotes": [
        "It presents with a cardiac phenotype, usually earlier than ATTRwt, typically during or after the sixth decade of life."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Thr60Ala",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Common in British and Irish populations",
        "phenotype": "Mixed phenotype of HF and polyneuropathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "Mixed phenotype with severe autonomic neuropathy",
          "evidence_sentence": "Thr60Ala is the most common variant in the British and Irish populations, presenting with a mixed phenotype of HF and polyneuropathy."
        }
      ],
      "functional_data": {
        "summary": "The Thr60Ala variant is associated with a mixed phenotype of heart failure and polyneuropathy.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Common in British and Irish populations.",
      "evidence_level": "Moderate evidence based on population studies.",
      "source_location": "Specific section on Thr60Ala in the Genetics section.",
      "additional_notes": "Neurologic manifestations are more prevalent at an earlier stage.",
      "key_quotes": [
        "Neurologic manifestations are more prevalent at an earlier stage, while cardiac involvement is usually present on diagnosis."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant TTR variants and penetrance data were extracted successfully."
  }
}